Authors:
LIU JW
SPENCE MJ
WALLACE PM
FORCIER K
HELLSTROM I
VESTAL RE
Citation: Jw. Liu et al., ONCOSTATIN M-SPECIFIC RECEPTOR MEDIATES INHIBITION OF BREAST-CANCER CELL-GROWTH AND DOWN-REGULATION OF THE C-MYC PROTOONCOGENE, Cell growth & differentiation, 8(6), 1997, pp. 667-676
Authors:
SIEMERS NO
KERR DE
YARNOLD S
STEBBINS MR
VRUDHULA VM
HELLSTROM I
HELLSTROM KE
SENTER PD
Citation: No. Siemers et al., CONSTRUCTION, EXPRESSION, AND ACTIVITIES OF L49-SFV-BETA-LACTAMASE, ASINGLE-CHAIN ANTIBODY FUSION PROTEIN FOR ANTICANCER PRODRUG ACTIVATION, Bioconjugate chemistry, 8(4), 1997, pp. 510-519
Authors:
DENARDO SJ
OGRADY LF
RICHMAN CM
GOLDSTEIN DS
ODONNELL RT
DENARDO DA
KROGER LA
LAMBORN KR
HELLSTROM KE
HELLSTROM I
DENARDO GL
Citation: Sj. Denardo et al., RADIOIMMUNOTHERAPY FOR ADVANCED BREAST-CANCER USING I-131 CHL6 ANTIBODY, Anticancer research, 17(3B), 1997, pp. 1745-1751
Authors:
DITZEL HJ
GARRIGUES U
ANDERSEN CB
LARSEN MK
GARRIGUES HJ
SVEJGAARD A
HELLSTROM I
HELLSTROM KE
JENSENIUS JC
Citation: Hj. Ditzel et al., MODIFIED CYTOKERATINS EXPRESSED ON THE SURFACE OF CARCINOMA-CELLS UNDERGO ENDOCYTOSIS UPON BINDING OF HUMAN MONOCLONAL-ANTIBODY AND ITS RECOMBINANT FAB FRAGMENT, Proceedings of the National Academy of Sciences of the United Statesof America, 94(15), 1997, pp. 8110-8115
Authors:
SJOGREN HO
ISAKSSON M
WILLNER D
HELLSTROM I
HELLSTROM KE
TRAIL PA
Citation: Ho. Sjogren et al., ANTITUMOR-ACTIVITY OF CARCINOMA-REACTIVE BR96-DOXORUBICIN CONJUGATE AGAINST HUMAN CARCINOMAS IN ATHYMIC MICE AND RATS AND SYNGENEIC RAT CARCINOMAS IN IMMUNOCOMPETENT RATS, Cancer research, 57(20), 1997, pp. 4530-4536
Authors:
TRAIL PA
WILLNER D
KNIPE J
HENDERSON AJ
LASCH SJ
ZOECKLER ME
TRAILSMITH MD
DOYLE TW
KING HD
CASAZZA AM
BRASLAWSKY GR
BROWN J
HOFSTEAD SJ
GREENFIELD RS
FIRESTONE RA
MOSURE K
KADOW KF
YANG MB
HELLSTROM KE
HELLSTROM I
Citation: Pa. Trail et al., EFFECT OF LINKER VARIATION ON THE STABILITY, POTENCY, AND EFFICACY OFCARCINOMA-REACTIVE BR64-DOXORUBICIN IMMUNOCONJUGATES, Cancer research, 57(1), 1997, pp. 100-105
Authors:
JEFFREY PD
BAJORATH J
CHANG CYY
YELTON D
HELLSTROM I
HELLSTROM KE
SHERIFF S
Citation: Pd. Jeffrey et al., THE X-RAY STRUCTURE OF AN ANTITUMOR ANTIBODY IN COMPLEX WITH ANTIGEN (VOL 2, PG 466, 1995), Nature structural biology, 3(12), 1996, pp. 1055-1055
Authors:
HELLSTROM I
TRAIL P
SIEGALL C
FIRESTONE R
HELLSTROM KE
Citation: I. Hellstrom et al., IMMUNOCONJUGATES AND IMMUNOTOXINS FOR THERAPY OF SOLID TUMORS, Cancer chemotherapy and pharmacology, 38, 1996, pp. 35-36
Authors:
REMSEN LG
MCCORMICK CI
ROMANGOLDSTEIN S
NILAVER G
WEISSLEDER R
BOGDANOV A
HELLSTROM KE
HELLSTROM I
KROLL RA
NEUWELT EA
Citation: Lg. Remsen et al., MR OF CARCINOMA-SPECIFIC MONOCLONAL-ANTIBODY CONJUGATED TO MONOCRYSTALLINE IRON-OXIDE NANOPARTICLES - THE POTENTIAL FOR NONINVASIVE DIAGNOSIS, American journal of neuroradiology, 17(3), 1996, pp. 411-418
Authors:
FIRESTONE RA
WILLNER D
HOFSTEAD SJ
KING HD
KANEKO T
BRASLAWSKY GR
GREENFIELD RS
TRAIL PA
LASCH SJ
HENDERSON AJ
CASAZZA AM
HELLSTROM I
Citation: Ra. Firestone et al., SYNTHESIS AND ANTITUMOR-ACTIVITY OF THE IMMUNOCONJUGATE BR96-DOX, Journal of controlled release, 39(2-3), 1996, pp. 251-259
Authors:
JOHNSTON JV
MALACKO AR
MIZUNO MT
MCGOWAN P
HELLSTROM I
HELLSTROM KE
MARQUARDT H
CHEN LP
Citation: Jv. Johnston et al., B7-CD28 COSTIMULATION UNVEILS THE HIERARCHY OF TUMOR EPITOPES RECOGNIZED BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CD8(-LYMPHOCYTES() CYTOLYTIC T), The Journal of experimental medicine, 183(3), 1996, pp. 791-800
Authors:
ROSOK MJ
YELTON DE
HARRIS LJ
BAJORATH J
HELLSTROM KE
HELLSTROM I
CRUZ GA
KRISTENSSON K
LIN H
HUSE WD
GLASER SM
Citation: Mj. Rosok et al., A COMBINATORIAL LIBRARY STRATEGY FOR THE RAPID HUMANIZATION OF ANTICARCINOMA BR96 FAB, The Journal of biological chemistry, 271(37), 1996, pp. 22611-22618
Authors:
MASS MK
REMSEN L
MCCORMICK C
HELLSTROM KE
HELLSTROM I
TRAIL PA
SIEGALL C
NEUWELT EA
Citation: Mk. Mass et al., NEUROTOXICITY OF CHEMOTHERAPEUTIC-AGENTS AND IMMUNOCONJUGATES DELIVERED AFTER BLOOD-BRAIN-BARRIER MODIFICATION - NEUROPATHOLOGICAL STUDIES, Annals of neurology, 38(2), 1995, pp. 342-342
Authors:
YELTON DE
ROSOK MJ
CRUZ G
COSAND WL
BAJORATH J
HELLSTROM I
HELLSTROM KE
HUSE WD
GLASER SM
Citation: De. Yelton et al., AFFINITY MATURATION OF THE BR96 ANTI-CARCINOMA ANTIBODY BY CODON-BASED MUTAGENESIS, The Journal of immunology, 155(4), 1995, pp. 1994-2004
Citation: Gc. Yang et al., ANTITUMOR IMMUNITY ELICITED BY TUMOR-CELLS TRANSFECTED WITH B7-2, A 2ND LIGAND FOR CD28 CTLA-4 COSTIMULATORY MOLECULES/, The Journal of immunology, 154(6), 1995, pp. 2794-2800
Authors:
SIEGALL CB
BACUS SS
COHEN BD
PLOWMAN GD
MIXAN B
CHACE D
CHIN DM
GOETZE A
GREEN JM
HELLSTROM I
HELLSTROM KE
FELL HP
Citation: Cb. Siegall et al., HER4 EXPRESSION CORRELATES WITH CYTOTOXICITY DIRECTED BY A HEREGULIN-TOXIN FUSION PROTEIN, The Journal of biological chemistry, 270(13), 1995, pp. 7625-7630
Authors:
KERR DE
SCHREIBER GJ
VRUDHULA VM
SVENSSON HP
HELLSTROM I
HELLSTROM KE
SENTER PD
Citation: De. Kerr et al., REGRESSIONS AND CURES OF MELANOMA XENOGRAFTS FOLLOWING TREATMENT WITHMONOCLONAL-ANTIBODY BETA-LACTAMASE CONJUGATES IN COMBINATION WITH ANTICANCER PRODRUGS, Cancer research, 55(16), 1995, pp. 3558-3563
Authors:
EDWARDS CP
FARR AG
MARKEN JS
NELSON A
BAJORATH J
HELLSTROM KE
HELLSTROM I
ARUFFO A
Citation: Cp. Edwards et al., CLONING OF THE MURINE COUNTERPART OF THE TUMOR-ASSOCIATED ANTIGEN H-L6 - EPITOPE MAPPING OF THE HUMAN AND MURINE L6 ANTIGENS, Biochemistry, 34(39), 1995, pp. 12653-12660